Do you have Sleep Apnea and High Blood Pressure, Heart Failure, or Atrial Fibrillation?
We invite you to see if the RESTEADY Study may be an option for you.
THE RESTEADY CLINICAL STUDY - NOW ENROLLING
Sleep apnea is common in people with cardiovascular conditions, such as high blood pressure, heart failure and atrial fibrillation. Additionally, the type of sleep apnea in these patients is often caused by both upper airway obstruction and irregular breathing.
This is why doctors and researchers are working to develop new medications specifically for people with both sleep apnea and cardiovascular conditions.
Right now, doctors at select centers throughout the US are conducting the RESTEADY Study. The study is evaluating an investigational oral medication to see if it is safe and effective in treating sleep apnea in people who also have high blood pressure, heart failure and/or atrial fibrillation.
The RESTEADY Study lasts about 10 weeks and involves up to 7 visits to your local study center for health exams and tests. Five of these visits will be overnight sleep studies to monitor your sleep apnea. If you qualify and choose to join the RESTEADY Study you will receive all study-related care and study medication at no cost, and will also be compensated for your time and travel to attend study visits.
SEE IF YOU QUALIFY
To see if you might qualify for the RESTEADY Study, and to get connected with your local study center to learn more, please take the pre-screening questionnaire below.